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Abstract.
BACKGROUND: Direct access physical therapy (DAPT) may result in improved patient outcomes and reduced healthcare costs.
Prognostic factors associated with spine-related outcomes and insurance claims with DAPT are needed.
OBJECTIVE: To identify factors that predict variations in outcomes for spine pain and insurance claims using DAPT.
METHODS: Individuals (N = 250) with spine pain were analyzed. Outcomes were classified into High, Low, or Did Not Meet
minimal clinically important difference (MCID) scores. Claims were categorized into low, medium, or high tertiles. Prognostic
variables were identified from patient information.
RESULTS: Females were more likely to meet High MCID (odds ratio [OR] 2.84 (95% CI = 1.32, 6.11) and Low MCID (OR
2.86, 95% CI = 1.34, 6.10). Higher initial ODI/NDI scores were associated with High MCID (OR 1.04, 95% CI = 1.07, 1.22)
and Low MCID (OR 0.91, 95% CI = 0.77, 1.07). Odds of a high claim were lowered by the absence of imaging (OR 0.04, 95%
CI = 0.02, 0.09) and an active versus passive treatment (OR 0.38, 95% CI = 0.18, 0.80).
CONCLUSION: Females and higher initial disability predicted favorable outcomes. The novel introduction of claims into the
prognostic modeling supports that active interventions and avoiding imaging may reduce claims.
Keywords: Prognosis, low back pain, neck pain, health care costs, direct access
1. Introduction1
Neck pain (NP) and low back pain (LBP) are two of2
the most common musculoskeletal conditions, with a3
global point prevalence of 4.9% [1] and 9.4% [2], re-4
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spectively. In the United States (US), 15% of all indi- 5
viduals report experiencing NP and 29% report LBP 6
within the previous three months [3]. Whereas a ma- 7
jority of persons with NP and LBP may have favorable 8
outcomes with or without treatment, a notable percent- 9
age of the population will go on to develop chronic or 10
recurring pain and disability. Over a third of individu- 11
als who develop NP will develop persistent symptoms 12
that last longer than six months [4]. Similarly, 24% 13
to 33% of individuals who experience activity-limiting 14
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LBP will continue to have recurring episodes through-15
out their lifetime [5,6].16
Numerous studies have examined prognostic fac-17
tors related to NP and LBP and predicting disability18
based on these factors. There is strong evidence that19
older age, a longer duration of symptoms, a history of20
neck problems, and co-existing musculoskeletal disor-21
ders are poor prognostic factors for non-specific NP [7]22
and high baseline disability, heightened psychologi-23
cal stress, older age, radicular symptoms, litigation,24
and physically demanding work are prognostic for25
LBP [8]. Interestingly, prognostic factors across stud-26
ies seem largely dependent on how outcomes were de-27
fined within the studies [9,10]. There is substantial28
variability amongst predictive models using different29
MCIDs on the Oswestry Disability Index (ODI) in the30
LBP population [10]. For NP, studies of prognostic fac-31
tors have lacked predictors for outcome from a mea-32
sure such as the Neck Disability Index (NDI) using dif-33
ferent MCIDs [9].34
We are unfamiliar with any modeling studies that35
have explored outcomes in patients who were seen via36
direct access to physical therapy. Direct access implies37
that patients are able to receive the services of a phys-38
ical therapist without seeing a medical provider first.39
This may have importance, since evidence suggests40
that patients seen in a direct access environment may41
have unique characteristics [11], and since prognostic42
models may be reflective of this uniqueness. Conse-43
quently, the study objectives were to model prognostic44
factors that predict variations in the degree of recov-45
ery, defined by Trichotomized (divided into three equal46
parts, low, medium, and high) MCID categories, and47
insurance claims, defined by trichotomized cost cat-48
egories (low, medium, and high), experienced by pa-49
tients utilizing direct access physical therapy for spine50
pain. We also evaluated the impact on the predictive51
models when using higher and lower MCIDs, as re-52
ported by the literature for both the ODI and NDI. Re-53
sults suggest modeling variations depend on different54
thresholds of success or claims costs.55
2. Materials and methods56
This study followed the Transparent Reporting of57
a multivariable prediction model for Individual Prog-58
nosis or Diagnosis (TRIPOD) initiative [12]. Key el-59
ements of the TRIPOD initiative include explanations60
of the source of data, participants, predictors, sample61
size, missing data, and statistical analysis methods.62
This was a secondary database exploration of ob- 63
servational data that included patients with spine pain 64
who chose direct access physical therapy. The sources 65
of data were the ATI (Assessment Technologies Inc.) 66
Patient Outcomes Registry paired with third party 67
claims, where total claims paid were provided by an 68
insurance payer. 69
Participants attended physical therapy via a direct 70
access between January 2012 and December 2014. 71
All patients received treatment across eight ATI phys- 72
ical therapy clinics within Greenville, South Carolina, 73
USA. The database contained 603 patients with 447 74
who had unique total claims and patient outcomes 75
data. Of these 447, 63% (280) received direct access 76
physical therapy. The final sample size was 250 sub- 77
jects. Thirty subjects were excluded because their ini- 78
tial ODI/NDI score was 6 10; therefore, a 10-point 79
change was not possible for the MCID. 80
2.1. Predictor variables 81
Eleven prognostic factors were available for anal- 82
ysis. Many of these have been recognized as prog- 83
nostic factors in the existing literature, including: age 84
[13], gender [14–16], initial ODI or NDI score [10,17, 85
18], initial pain score [19], widespread pain [20–22], 86
chronicity of symptoms [14,18,20], the presence or ab- 87
sence of radicular pain [21,23], and whether patients 88
used prescribed drugs [24]. Widespread pain was de- 89
fined as the presence of strong leg pain, distal leg pain, 90
or upper body pain [20] or a drawing of areas on a 91
pain diagram [25]. Chronicity level described the du- 92
ration of LBP [14,18,20]. We classified chronicity as 93
acute (< 30 days), subacute (31–90 days), and chronic 94
(> 90 days). These categories were similar to those of 95
Bekkering et al. [14] who found that duration of symp- 96
toms was the most consistent factor across their prog- 97
nostic modeling [14]. Radicular pain was defined as leg 98
pain [21] or pain below the leg [23] in addition to back 99
pain. 100
Because this was a direct access population, we in- 101
cluded additional variables such as whether a partic- 102
ipant saw a medical specialist, received imaging, or 103
was managed with an active versus passive approach 104
to physical therapy. Using a slight variation of an index 105
measure created by Childs et al. [26], a participant’s 106
plan of care was considered active when greater than 107
75% of the interventions included active Current Pro- 108
cedural Terminology treatment codes. 109
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Table 1
Descriptive statistics categorized by High MCID Met, Low MCID Met, and failed to meet MCID values (N = 250)
Variable High met (> 10 point Low Met (4 to 10 point Failed to meet (< 4 point
MCID change on MCID change on MCID change on p-value
ODI/NDI) N = 101 ODI/NDI) N = 106 ODI/NDI) N = 43
Age 46.38 (11.69) 45.37 (12.75) 47.84 (10.84) 0.52
Gender 79 = Female 83 = Female 24 = Female 0.01
22 = Male 23 = Male 19 = Male
Initial ODI/NDI 22.18 (8.22) 14.57 (4.24) 16.58 (5.19) < 0.01
Initial pain score 6.90 (2.03) 5.73 (2.37) 6.19 (1.68) 0.01
Chronicity level 39 = Acute 29 = Acute 9 = Acute 0.20
12 = Subacute 19 = Subacute 7 = Subacute
50 = Chronic 58 = Chronic 27 = Chronic
Widespread pain 91 = No 102 = No 38 = No 0.14
10 = Yes 4 = Yes 5 = Yes
Saw specialist 48 = No 60 = No 20 = No 0.34
53 = Yes 46 = Yes 23 = Yes
Received imaging 57 = No 65 = No 23 = No 0.63
44 = Yes 41 = Yes 20 = Yes
Radicular pain 70 = No 73 = No 28 = No 0.88
31 = Yes 33 = Yes 15 = Yes
Prescribed drugs 83 = No 92 = No 37 = No 0.63
18 = Yes 14 = Yes 6 = Yes
Days in care 50.23 (57.57) 51.78 (59.99) 39.30 (28.88) 0.44
Total visits 8.69 (5.61) 8.04 (4.14) 7.37 (3.47) 0.28
Total PT costs 966.30 (835.96) 945.94 (984.35) 774.46 (841.03) 0.48
Total overall costs 2699.27 (8375.15) 2623.74 (6303.53) 3593.39 (11075.45) 0.79
Active more than passive treatment 77 = No 76 = No 36 = No 0.30
24 = Yes 30 = Yes 7 = Yes
MCID – Minimally Clinically Important Difference; Bold indicates Significance 6 0.05; acute (30 days), subacute (31 to 90 days), chronic (>
90 days).
2.2. Outcome variables110
Two outcomes were: 1) change scores in disabil-111
ity, using ODI or NDI (hereby defined as ODI/NDI),112
and 2) insurance costs. ODI/NDI scores were recorded113
at baseline and discharge from physical therapy. ODI/114
NDI raw scores ranged from 0 (no disability) to 50 (to-115
tal disability).116
ODI/NDI outcomes were categorized based on a117
range of reported MCIDs from the literature where im-118
provement in the raw score typically included values in119
the range of 4 to 11 points [27–35]; with the most con-120
sistent value set at 10 points [31,33,35,36]. Based on121
these parameters from the literature, we operationally122
defined the ODI/NDI outcomes as: 1) High MCID Met123
(> 10 point change), Low MCID Met (4 to 10 point124
change), and Failed to Meet MCID (< 4 point change).125
Since no threshold data exists (to categorize levels of126
claims) in the literature, we trichotomized by tertiles127
(three equal representative groups by numbers) as low128
cost (< $793), moderate cost ($1793–$1881), and high129
cost (> $1881) to distinguish extreme differences.130
2.3. Missing values131
After refining the dataset to 250, there were very few132
instances (< 1%) of missing data within the predictors 133
and 0% missing data for outcomes variables. Missing 134
data of the predictors were evaluated using Little’s test 135
for missing completely at random. Because there were 136
so few instances of missing values we elected not to 137
use imputation and instructed the statistical software 138
to perform a complete case analysis, ignoring cases of 139
missing values. 140
2.4. Data analysis 141
SPSS version 23.1 was used for all analyses. De- 142
scriptive statistics were used to describe all base- 143
line sample characteristics with analysis of variance 144
(ANOVA) and t-tests used to divide MCID categorical 145
groups. 146
Univariate and multivariate multinomial logistic re- 147
gression was used with the “failed to meet” MCID and 148
lowest claims data tertiles used as the referent vari- 149
ables. Multinomial regression always uses a multiclass 150
analysis when two distinct categorical variables are po- 151
tential outcomes. Multinomial regression is used to ex- 152
plain the relationship between one nominal dependent 153
variable and one or more independent variables. Prog- 154
nostic variables that were statistically significant for 155
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Table 2
Bivariate relationships and multinomial logistic regression analyses: Odds ratios and 95% confidence inter-
vals. Dependent Variable= ODI/NDI Outcome per Utilization Trichotomized, Referent Category= failed to
meet MCID (N = 250)
Variable (reference) Multinomial categorization Odds ratio (95% p-value
outcome per utilization confidence unterval)
Age Higher MCID Met 0.99 (0.96, 1.02) 0.50
Lower MCID Met 0.98 (0.95, 1.01) 0.26
Gender (Female) Higher MCID Met 2.84 (1.32, 6.11) < 0.01
Lower MCID Met 2.86 (1.34, 6.10) < 0.01
Initial ODI/NDI score Higher MCID Met 1.04 (1.07, 1.22) < 0.01
Lower MCID Met 0.91 (0.84, 0.98) 0.01
Initial pain score Higher MCID Met 1.18 (0.99, 1.40) 0.06
Lower MCID Met 0.91 (0.77, 1.07) 0.25
Widespread pain (No) Higher MCID Met 1.20 (0.38, 3.74) 0.76
Lower MCID Met 3.36 (0.86, 13.16) 0.08
Chronicity level Higher MCID Met a. 2.34 (0.99, 5.55) 0.05
(a = acute, b = subacute) b. 0.93 (0.33, 2.63) 0.89
Lower MCID Met a. 1.50 (0.63, 3.60) 0.36
b. 1.26 (0.47, 3.37) 0.64
Saw specialist (No) Higher MCID Met 1.04 (0.51, 2.13) 0.91
Lower MCID Met 1.50 (0.74, 3.06) 0.26
Received imaging (No) Higher MCID Met 1.13 (0.56, 2.31) 0.75
Lower MCID Met 1.38 (0.68, 2.82) 0.38
Radicular pain (No) Higher MCID Met 1.21 (0.57, 2.58) 0.62
Lower MCID Met 1.19 (0.56, 2.51) 0.66
Prescribed drugs (No) Higher MCID Met 0.75 (0.28, 2.04 0.57
Lower MCID Met 1.07 (0.38, 2.99) 0.90
Active more than passive treatment (No) Higher MCID Met 0.62 (0.25, 1.58) 0.32
Lower MCID Met 0.49 (0.20, 1.23) 0.13
MCID – Minimally Clinically Important Difference; Bold indicates Significance 6 0.05; acute (30 days),
subacute (31 to 90 days), chronic (> 90 days).
the univariate measures were carried forward to the156
multivariate analyses. For all analyses, a p value of less157
than 0.05 was used to discriminate statistical signifi-158
cance.159
3. Results160
Table 1 provides descriptive variables of the study161
for 250 patients with LBP and NP, categorized by162
MCID changes on the ODI/NDI, respectively. The163
groups were different (p < 0.05) based on gender and164
ODI/NDI score. Just over eighty-two percent (82.8%)165
of the patients (206/250) were categorized in the High166
Met or Low Met MCID groups, while the remaining167
17.2% (43/250) were categorized in the Failed to Meet168
MCID group.169
Table 2 provides the bivariate, multinomial logis-170
tic regression analyses using ODI/NDI outcomes as171
the dependent variable while also trichotomizing High172
MCID Met and Low MCID Met. The Failed to Meet173
MCID was used as the referent category. Female gen-174
der and initial ODI/NDI score were found to be sta-175
tistically significant in both the High and Low MCID176
Met groups. Females had 2.84 (95% CI = 1.32, 6.11) 177
greater odds of being in the High MCID and 2.86 (95% 178
CI = 1.34, 6.10) greater odds in being in the Low 179
MCID Met. Individuals with a higher initial ODI/NDI 180
score had 1.04 (95% CI = 1.07, 1.22) greater odds of 181
being in a High MCID and lower odds of being in a 182
Low MCID; 0.91 (95% CI = 0.77, 1.07). 183
Table 3 represents the bivariate, multinomial logistic 184
regression analyses using claims of care as the depen- 185
dent variable while also trichotomizing High, Medium, 186
and Low claims. The lowest trichotomized claims of 187
care was used as the referent category (< $793). Not 188
receiving imaging resulted in lower odds of being in 189
the High and Medium claims groups respectively: 0.04 190
(95% CI = 0.02, 0.09) and 0.15 (95% CI = 0.07, 191
0.36). Other significant protective factors (against high 192
claims) included not seeing a specialist 0.44 (95% 193
CI = 0.24, 0.82), not receiving prescribed drugs 0.36 194
(95% CI = 0.14, 0.18), and having a higher percent- 195
age of active versus passive treatment 0.38 (95% CI = 196
0.18, 0.80). 197
A hierarchical multivariate, multinomial logistic re- 198
gression modeling was performed using ODI/NDI out- 199
come per utilization trichotomized as the dependent 200
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Table 3
Bivariate relationships and multinomial logistic regression analyses: Odds ratios and 95%
confidence intervals. Dependent Variable= Trichotomized Claims of Care, Referent Category
= Lowest Trichotomized Claims of Care (N = 250)
Variable (reference) Multinomial categorization Odds ratio (95% p-value
outcome per utilization confidence interval)
Age High claims 0.99 (0.96, 1.01) 0.29
Medium claims 0.99 (0.97, 1.02) 0.56
Gender (Female) High claims 0.70 (0.35, 1.39) 0.30
Medium claims 1.00 (0.48, 2.07) 1.00
Initial ODI/NDI score High claims 1.01 (0.97, 1.06) 0.54
Medium claims 1.01 (0.96, 1.05) 0.80
Initial pain score High claims 1.00 (0.87, 1.15) 0.96
Medium claims 1.03 (0.90, 1.19) 0.66
Widespread pain (No) High claims 0.80 (0.28, 2.25) 0.67
Medium claims 2.46 (0.61, 9.86) 0.20
Chronicity level High claims a) 0.92 (0.46, 1.86) 0.82
(a = acute, b = subacute) b) 0.92 (0.39, 2.19) 0.85
Medium claims a) 1.59 (0.80, 3.16) 0.19
b) 1.09 (0.45, 2.66) 0.85
Saw specialist (No) High claims 0.44 (0.24, 0.82) 0.01
Medium claims 0.95 (0.51, 1.77) 0.87
Received imaging (No) High claims 0.04 (0.02, 0.09) < 0.01
Medium claims 0.15 (0.07, 0.36) < 0.01
Radicular pain (No) High claims 0.54 (0.28, 1.06) 0.07
Medium claims 0.66 (0.33, 1.30) 0.23
Prescribed drugs (No) High claims 0.36 (0.14, 0.18) 0.02
Medium claims 0.88 (0.32, 2.40) 0.80
Active more than High claims 0.38 (0.18, 0.80) 0.01
passive treatment (No) Medium claims 0.47 (0.21, 1.02) 0.06
Bold indicates Significance6 0.05; low claims (< $793), medium claims ($793–$1881), high
claims (> $1881).
variable, and “failed to meet” MCID as the referent201
category (Table 4). Among the High MCID Met group202
(> 10) as well as the Low MCID Met group (4–10):203
initial ODI/NDI score and female gender were found204
to be statistically significant. Higher initial ODI/NDI205
scores had 1.15 (95% CI = 1.06, 1.24) greater odds of206
being stratified within the High MCID Met group, and207
0.91 (95% CI = 0.84, 0.99) greater odds of being in208
the Low MCID Met group. Females had 2.83 (95% CI209
= 1.23, 6.55) greater odds of being categorized within210
the High MCID Met group, as well as, 3.28 (95% CI211
= 1.47, 7.30) greater odds of being in the Low MCID212
Met group.213
A hierarchical multinomial logistic regression mod-214
eling was performed using trichotomized claims of215
care as the dependent variable and the lowest tri-216
chotomized claims of care group (< $793) as the refer-217
ent category (Table 5). Among the higher claims group218
(> $1881) and the medium claims group ($793–1881),219
not receiving imaging and a higher ratio of active treat-220
ment more than passive were both statistically signif-221
icant and protective (less likely to have higher costs):222
0.04 (95% CI = 0.01, 0.10) and 0.23 (95% CI = 0.09,223
0.55) times lower odds of meeting the high claims224
Table 4
Hierarchical Multinomial Logistic Regression Modeling including p
values, odds ratios, and 95% confidence intervals. Dependent Vari-
able = ODI/NDI Outcome per Utilization Trichotomized, Referent
Category = failed to meet MCID (N = 250)
Variable Odds ratios (95% p-value
confidence interval)
Higher MCID Met (> 10)
Initial ODI/NDI score 1.15 (1.06, 1.24) < 0.01
Initial pain score 1.06 (0.87,1.28) 0.57
Gender (Female) 2.83 (1.23, 6.55) 0.02
Widespread pain (No) 1.45 (0.40, 5.30) 0.57
Chronicity level a. 2.35 (0.92, 5.99) 0.08
(a = acute, b = subacute) b. 0.78 (0.26, 2.40) 0.67
Active more than passive 0.52 (0.19, 1.44) 0.21
treatment (Yes)
Lower MCID Met (4 to 10 points)
Initial ODI/NDI score 0.91 (0.84, 0.99) 0.04
Initial pain score 0.93 (0.78, 1.11) 0.42
Gender (Female) 3.28 (1.47, 7.30) < 0.01
Widespread pain (No) 2.81 (0.63, 12.63) 0.18
Chronicity level a. 1.25 (0.50, 3.16) 0.63
(a = acute, b = subacute) b. 1.19 (0.42, 3.38) 0.75
Active more than passive 0.49 (0.19, 1.28) 0.14
treatment (Yes)
MCID – Minimally Clinically Important Difference; Bold indicates
Significance 6 0.05; acute (30 days), subacute (31 to 90 days),
chronic (> 90 days).
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Table 5
Hierarchical Multinomial Logistic Regression Modeling including p
values, odds ratios, and 95% confidence intervals. Dependent Vari-
able = Trichotomized Claims of Care, Referent Category = Lowest
Trichotomized Claims of Care (N = 250)
Variable Odds ratios (95% p-value
confidence interval)
High claims (> $1881)
Radicular pain (No) 0.55 (0.25, 1.23) 0.15
Received imaging (No) 0.04 (0.01, 0.10) < 0.01
Saw specialist (No) 0.63 (0.30, 1.32) 0.22
Prescribed drugs (No) 0.81 (0.27, 2.43) 0.71
Active more than passive 0.23 (0.09, 0.55) < 0.01
treatment (Yes)
Medium claims ($793–1881)
Radicular pain (No) 0.72 (0.35, 1.50) 0.38
Received imaging (No) 0.13 (0.05, 0.31) < 0.01
Saw specialist (No) 1.11 (0.57, 2.18) 0.76
Prescribed drugs (No) 1.63 (0.52, 5.12) 0.40
Active more than passive 0.39 (0.17, 0.89) 0.03
treatment (Yes)
Low claims (< $793)
Bold indicates Significance 6 0.05.
group respectively as well as 0.13 (95% CI = 0.05,225
0.31) and 0.39 (95% CI = 0.17, 0.89) lower odds of226
falling in the medium claims group respectively.227
4. Discussion228
We identified a variety of prognostic variables that229
were statistically significant for patients meeting high230
and Low MCID outcomes, which is a novel concept231
in that non-specific NP and LBP depended on the232
outcome selected. Our results indicate that the statis-233
tical significance of prognostic variables determined234
by different models depends largely on how outcome235
is defined, which corroborates with earlier work con-236
ducted by Schwind et al. [10] that concluded differ-237
ent MCID scores can affect the accuracy of prognos-238
tic factors when using the ODI as the outcome mea-239
sure. In this study, the bivariate relationship and multi-240
nomial regression analyses revealed several statisti-241
cally significant prognostic variables for the higher and242
the lower MCID met groups using the ODI/NDI as243
the dependent variable. Females had higher odds of244
meeting both the Low MCID and High MCID than245
males, which may suggest females could be predicted246
to have better outcomes. However, this finding runs247
counter to reports that the female gender is generally248
predicted to have poorer outcomes when experiencing249
LBP [15,16,18]. A possible explanation for this dis-250
crepancy is the present study included physical ther-251
apy intervention, whereas those studies did not include252
treatment by a physical therapist.253
Our results suggest initial disability scores mea- 254
sured by the ODI/NDI can predict whether a patient 255
will benefit from physical therapy treatment. Base- 256
line ODI/NDI scores have been found as a prognos- 257
tic factor elsewhere in the literature for both LBP and 258
NP [10,17,37,38]. Cook et al. [17] included initial ODI 259
score as a prognostic factor of interest to examine 260
generic predictors of outcome in LBP patients. They 261
found that lower baseline ODI scores were individual 262
prognostic variables within two of 4 of their statistical 263
models [17]. Schwind et al. [10] identified initial ODI 264
score as a prognostic factor when using an MCID of 5 265
or 10 points on the ODI. Few studies have linked ini- 266
tial neck disability to outcome. According to De Pauw 267
et al. [37], higher NDI scores at baseline are related to 268
poorer outcomes. Likewise, patients with a NDI score 269
of less than 18/50 at baseline may be more likely to 270
perceive improvement after treatment [38]. McLean et 271
al. [7] concluded in their review of the literature that 272
there is inconclusive evidence for the predictive power 273
of baseline disability and NP for subjects with non- 274
specific NP, which is in agreement with the findings of 275
Cecchi et al. [39]. 276
The choice to trichotomize the MCID into High 277
Met, Low Met, and Failed To Meet groups for the 278
ODI/NDI was based on reported literature. A lower 279
range of 4–6 points has been suggested to be a useful 280
clinical cut-off score to determine if patients’ disability 281
had improved or not after a 6 week period [40]. This 282
lower MCID threshold may be appropriate for patients 283
with acute back pain because of its ability to establish 284
a meaningful change after 6 weeks. Hägg et al. [33] 285
found that an MCID of 10 was the lowest number they 286
could identify within a 95% confidence interval. Os- 287
telo and de Vet [34] proposed that acute sufferers of 288
LBP may have higher ODI scores than those suffering 289
from chronic LBP and suggested that 10 was an ac- 290
ceptable MCID value on the ODI, based on previous 291
research. This recommendation was bolstered by the 292
fact that Lauridsen et al. [32] found an average of 11 293
for their MCID across a stratification of patients with 294
differing baseline ODI values and symptoms. 295
Five studies have reported on the MCID for the 296
NDI [41–45] with scores ranging from 3.5 to 10 points 297
depending on the study population. Pool et al. [43] 298
found an MCID of 3.5 points by comparing NDI 299
change scores and global perceived change using the 300
area under the curve. Citing his expert opinion, the de- 301
veloper of the NDI, Vernon [46], concluded that 3.5 302
is the most appropriate MCID for the NDI. However, 303
most studies report an MCID of 9.5 to 10 points in 304
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patients with mechanical NP or cervical radiculopa-305
thy [42,44,47]. Because a range of values from 4 to 11306
have been reported, it would stand to reason that a sim-307
ilar range of MCIDs for the ODI/NDI would be appro-308
priate for use in our logistic regression analysis. There-309
fore, the MCIDs for the disability outcome measures310
were trichotomized as greater than 10 point change311
(High MCID Met), a 4 to10 point change (Low MCID312
Met), and < 4 point change (Failed To Meet).313
Patients in this study who did not have imaging314
had lower insurance claims. To our knowledge, imag-315
ing has not been used as a prognostic factor to de-316
termine claims. However, the suggestion that imaging317
is usually an unnecessary expense is supported else-318
where [48]. The most recent clinical practice guide-319
lines (CPG) for LBP do not support imaging unless a320
patient is a surgical candidate [49].321
An active approach to physical therapy versus a322
passive approach was associated with lower claims.323
An active approach to physical therapy for LBP has324
been suggested elsewhere as leading to better patient325
outcomes [50], which could explain why active ap-326
proach is also less expensive. Linton et al. [51] demon-327
strated patients who received early active physical ther-328
apy were at a significantly reduced risk for develop-329
ing chronic back pain. These findings have been sup-330
ported by others in the literature [52,53]. In theory, a331
more efficient approach to therapy would require less332
visits and less money spent by both the patient and the333
insurance companies.334
4.1. Limitations335
Our results should be interpreted within the limita-336
tions of our study. There are other potential prognos-337
tic factors that were not accounted for in the present338
study. These include work status [20,22], psychosocial339
factors [16,54–58], and eligibility for the spinal manip-340
ulation clinical prediction rule (CPR) [17]. Addition-341
ally, other variables pertinent to LBP including pain,342
total visits, and self-perception of recovery were not343
used in this study. With multinomial regression, there344
is a chance some patients may have been misclassified.345
Finally, the retrospective nature of the data analysis did346
not allow blinding to the prognostic factors nor were347
predetermined cut points for disability or claims set be-348
forehand.349
5. Conclusions350
Initial ODI/NDI scores and the female gender were351
prognostic for reaching both a low and high MCID352
met threshold in our secondary data analysis of patients353
seeking physical therapy via direct access. Addition- 354
ally, an active versus passive approach to physical ther- 355
apy and the absence of imaging were both associated 356
with lower total claims of care. Future research should 357
investigate the effect of prognostic factors that are con- 358
sistently observed over various predictive models and 359
their effect on claims in the direct access setting. 360
Key Points: 361
1. Our results suggest initial disability scores mea- 362
sured by the ODI/NDI can predict whether a pa- 363
tient will benefit from physical therapy treatment; 364
2. Not receiving imaging and a higher ratio of active 365
treatment more than passive were associated with 366
lower costs; 367
3. Variable MCID’s did not change the predictors; 368
4. Medium and high costs groups had the same 369
prognostic predictors 370
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